MANDY YI: Open Payments
NPI 1932659984 · FLORHAM PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 15 payments from 8 companies in 2025. Trend: 2023 $267 · 2024 $309 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $125 |
| PFIZER INC. | 5 | $83 |
| Novo Nordisk Inc | 4 | $70 |
| Dexcom, Inc. | 1 | $35 |
| Exact Sciences Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
Products named: Veklury, Wegovy, Dexcom G6 Transmitter, PREVNAR 20, ELIQUIS, The Cologuard Plus Collection Kit, ZEPBOUND, Veozah.
Industry payments across NJ — which companies pay providers there.
